8-K: KALA BIO Settles $10.6M Debt for $2M

KALA BIO, Inc. announced the full satisfaction of its $10.6 million debt obligations to Oxford Finance, LLC through a $2 million payment.

Summary

• KALA BIO, Inc. (the Company) previously entered into a Loan Settlement Agreement with Oxford Finance, LLC on November 25, 2025, as disclosed in a prior Form 8-K.
• This agreement was a direct consequence of events of default by the Company and its subsidiary, Combangio, Inc., under the Loan and Security Agreement dated May 4, 2021.
• The Settlement Agreement stipulated that the Company would pay Oxford Finance, LLC $2 million.
• On December 26, 2025, the Company successfully made the $2 million payment to Oxford Finance, LLC.
• As a result of this payment, all obligations under both the Settlement Agreement and the original Loan Agreement have been fully satisfied and released.
• The aggregate liability due to Oxford Finance, LLC, which was approximately $10.6 million, has now been completely settled and released.

Sentiment

Score: 7

Explanation: The settlement of a significant debt at a substantial discount is a positive financial event, removing a major liability and improving the balance sheet. However, the underlying reason for the settlement (events of default) indicates past financial distress, which tempers the overall sentiment.

Positives

• Successfully settled an approximate $10.6 million liability for a payment of $2 million, representing a significant reduction in the Company's debt burden.
• All obligations under the Loan Settlement Agreement and the original Loan and Security Agreement have been fully satisfied and released, removing a major financial overhang.
• Eliminates potential legal and financial repercussions that could have arisen from the previously disclosed events of default.

Negatives

• The necessity for the settlement arose from prior events of default by the Company and its subsidiary under the original Loan and Security Agreement.
• The Company incurred a $2 million cash outflow to finalize the settlement.

Risks

• Past events of default under the Loan and Security Agreement indicate potential historical financial instability or operational challenges.
• While the immediate liability is resolved, the history of default could potentially influence future credit terms or access to financing.

Future Outlook

The filing does not provide explicit forward-looking statements or guidance beyond the immediate impact of the debt settlement. The resolution of this significant liability is expected to improve the company's financial flexibility and balance sheet strength.

Management Comments

• KALA BIO, INC. By: /s/ David Lazar David Lazar Chief Executive Officer

Industry Context

The settlement of a significant debt obligation, particularly following events of default, is a common occurrence in the biotechnology sector, especially for companies in development stages that rely heavily on external financing. Resolving such liabilities can significantly improve a company's financial standing and attractiveness to future investors, aligning with broader industry trends of financial restructuring to support ongoing research and development or commercialization efforts.

Comparison to Industry Standards

• NA

Legal Proceedings

• The settlement resolves potential legal proceedings or enforcement actions that could have arisen from the events of default under the Loan and Security Agreement.

Stakeholder Impact

• Shareholders: The significant reduction in debt and removal of a major liability could positively impact shareholder value by improving the company's financial health and reducing risk.
• Creditors: Oxford Finance, LLC has received a partial payment and released all claims, resolving their exposure related to the defaulted loan.
• Employees: A stronger financial position may provide greater stability and confidence for employees.

Next Steps

• The company has satisfied all obligations under the Loan Settlement Agreement and the Loan and Security Agreement, implying no further immediate actions related to this specific debt.

Key Dates

Recommendation

While the debt settlement is a significant positive, reducing a $10.6 million liability to $2 million, the underlying events of default suggest past financial challenges. This resolution removes a major overhang but does not inherently signal a strong growth trajectory or fundamental business improvement. Investors should hold to observe future operational performance and strategic direction now that this financial burden is lifted, rather than immediately buying or selling based solely on this debt restructuring.

Keywords

KALA BIO, KALA, debt settlement, loan agreement, Oxford Finance, financial restructuring, default, biotechnology, Combangio